University of Michigan
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Michigan sits in the top decile of US sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count).
University of Michigan: 1,327 sponsored US clinical trials, 179 recruiting.
University of Michigan sponsors 1,327 registered US clinical trials on ClinicalTrials.gov, 179 of them currently recruiting, and 971 completed. 94 of these trials are in Phase 3-4 (later-stage) and 159 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 15 trials.
Top-decile sponsor footprint
University of Michigan ranks in the top decile of sponsors by registered trial count (#19 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
971 of 1,083 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,327 total, page 11 of 27
Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19
NCT04706533
Fluoride Retention in the Mouth of Older Adults
NCT04239872
Telemedicine Enabling Patients in Self-care Behaviors
NCT04297735
Oral Hydroxychloroquine (HCQ) for Retinitis Pigmentosa Caused by P23H- Rhodopsin (RHO)
NCT04120883
Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
NCT04181255
Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors
NCT04103346
Vigor and the LDR in Parkinson Disease
NCT04821830
Sodium Diet Effect on Aldosterone and Urinary RNA (SALTY)
NCT04168073
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis
NCT04205396
Reducing Cannabis Use for Sleep Among Adults Using Medical Cannabis
NCT03964974
Neurally Targeted Cognitive Training to Augment CBT Outcomes in Pediatric Anxiety
NCT04157296
Controlling Hypertension Through Education and Coaching in Kidney Disease
NCT04087798
Social Media Intervention for Cannabis Use in Emerging Adults
NCT04187989
International Study of Inflammation in COVID-19
NCT04818866
Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity
NCT04117347
Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis
NCT04004416
Hydrogen Breath Test an Instrument to Predict Rifaximin-Response in Irritable Bowel Syndrome Predominant Diarrhea
NCT03729271
Alternating Urine Redox Status Of Consecutive Menstrual Cycles
NCT04157309
Evaluation of the Healthy Michigan Plan Section 1115 Community Engagement Requirement Waiver
NCT04207905
Clinical Outcomes of Resective Surgical Treatment of Peri-Implantitis With or Without Implantoplasty
NCT04259840
Improving Nutritional Choices in Adolescents
NCT03693144
Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)
NCT04007523
The Development of Reward Response to Food in Infancy
NCT04114123
Theta Burst Transcranial Magnetic Stimulation of Fronto-parietal Networks: Modulation by Mental State
NCT04010461
Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation
NCT04069637
Ultrasonography and Cone-Beam Computed Tomography for Peri-implant Tissue Evaluation
NCT04488302
Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults
NCT03863353
A Couples-based Intervention for Transgender Women and Their Partners
NCT04067661
Short Dental Implants (5 mm) Versus Long Dental Implants (10 mm)
NCT04144322
Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)
NCT04644783
Building Collaborations to Address Drug Problems in the United States and China
NCT04021030
Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease
NCT04009668
Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
NCT04066829
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
NCT03539861
A New Model to Reach Vulnerable Older Adults With Pain Self-management Support
NCT04095650
Improving Employment and Reducing Recidivism Among Prison Offenders Via Virtual Interview Training Tool
NCT03937128
Active Body and Mind Intervention for Older Adults
NCT05233813
Improving Employment and Reducing Recidivism Among Prison Offenders Via Virtual Interview Training Tool (MICHR)
NCT04140942
Non-Pharmacological Interventions on Patient Experience and Healthcare Utilization in Adult Cardiac Surgery Patients
NCT04051021
Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder
NCT04317495
Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation
NCT03607500
Alcohol Screening and Pre-Operative Intervention Research Study
NCT03929562
A Comparative Assessment of Transfemoral Prosthetic Sockets
NCT04038580
Adaptive Interventions for Prevention/Intervention for Youth Substance Abuse
NCT03928756
MVP RCT: Mind and Voice Project Randomized Control Trial
NCT04018807
Therapeutic Peri-implant Maintenance with Laser Therapy
NCT04251793
The University of Michigan PCOS Intervention Using Nutritional Ketosis
NCT03987854
Diabetes Outcomes and Unmet Resources
NCT03950973
Pilot Testing a Patient Safety Display in the Hospital Setting
NCT03950921
Loratadine for Improvement of Bone Pain in Patients With Chronic Granulocyte-Colony Stimulating Factor (G-CSF) Use
NCT03883386
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 79 |
| Phase 2 | 80 |
| Phase 3 | 25 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the University of Michigan pipeline
179 recruiting of 1,327 indexed (13% open); 971 completed (73%).
Phase mix: 94 late (III/IV) vs 159 early (I/II) (early-phase heavy).
Top condition: Depression (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Michigan: open-pipeline peers nationwide
Peers matched on 1,327 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
University of Michigan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,327 trials (± recruiting share)
- Eli Lilly and Company · 1,341 trials · 9% recruiting
- GlaxoSmithKline · 1,345 trials · 4% recruiting
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Colorado, Denver · 1,283 trials · 21% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Wayne State University · 13% recruiting · 163 trials
- Case Comprehensive Cancer Center · 14% recruiting · 407 trials
- Albany Medical College · 13% recruiting · 52 trials
- Taiho Oncology · 13% recruiting · 52 trials
Related
What to do with this University of Michigan page
1,327 registered trials is a research-attention snapshot, not an endorsement of University of Michigan or any single study.
- 179 of University of Michigan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Michigan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Michigan pipeline card: 1,327 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.